70 related articles for article (PubMed ID: 20643553)
1. Concise synthesis of 5,6-dihydrovaltrate leading to enhanced Rev-export inhibitory congener.
Tamura S; Fujiwara K; Shimizu N; Todo S; Murakami N
Bioorg Med Chem; 2010 Aug; 18(16):5975-80. PubMed ID: 20643553
[TBL] [Abstract][Full Text] [Related]
2. Bioisostere of valtrate, anti-HIV principle by inhibition for nuclear export of Rev.
Tamura S; Shimizu N; Fujiwara K; Kaneko M; Kimura T; Murakami N
Bioorg Med Chem Lett; 2010 Apr; 20(7):2159-62. PubMed ID: 20207540
[TBL] [Abstract][Full Text] [Related]
3. Prenylcoumarin with Rev-export inhibitory activity from Cnidii Monnieris Fructus.
Tamura S; Fujitani T; Kaneko M; Murakami N
Bioorg Med Chem Lett; 2010 Jun; 20(12):3717-20. PubMed ID: 20493693
[TBL] [Abstract][Full Text] [Related]
4. [HIV-1 Rev and related inhibitors].
Cao Y; Liu XY
Yao Xue Xue Bao; 2007 Apr; 42(4):347-51. PubMed ID: 17633198
[TBL] [Abstract][Full Text] [Related]
5. New Rev-export inhibitor from Alpinia galanga and structure-activity relationship.
Tamura S; Shiomi A; Kaneko M; Ye Y; Yoshida M; Yoshikawa M; Kimura T; Kobayashi M; Murakami N
Bioorg Med Chem Lett; 2009 May; 19(9):2555-7. PubMed ID: 19342232
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and application of a screening anti-HIV-1 drug model targeted nuclear trafficking of virus RNA].
Liu ZL; Li XY; Zhang Q; Jia PP; Yang L; Wei XL; Jiang JD; Cen S
Yao Xue Xue Bao; 2010 Feb; 45(2):257-62. PubMed ID: 21351437
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Rev function and RNA nuclear-cytoplasmic export.
Cochrane A
Methods Mol Biol; 2014; 1087():103-14. PubMed ID: 24158817
[TBL] [Abstract][Full Text] [Related]
8. A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.
Daelemans D; Afonina E; Nilsson J; Werner G; Kjems J; De Clercq E; Pavlakis GN; Vandamme AM
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14440-5. PubMed ID: 12374846
[TBL] [Abstract][Full Text] [Related]
9. The export receptor Crm1 forms a dimer to promote nuclear export of HIV RNA.
Booth DS; Cheng Y; Frankel AD
Elife; 2014 Dec; 3():e04121. PubMed ID: 25486595
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of an RNA-binding p-terphenylene scaffold that inhibits HIV-1 Rev protein function.
González-Bulnes L; Ibáñez I; Bedoya LM; Beltrán M; Catalán S; Alcamí J; Fustero S; Gallego J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13405-9. PubMed ID: 24214163
[No Abstract] [Full Text] [Related]
11. Identification of benzenesulfonamide quinoline derivatives as potent HIV-1 replication inhibitors targeting Rev protein.
Zhong F; Geng G; Chen B; Pan T; Li Q; Zhang H; Bai C
Org Biomol Chem; 2015 Feb; 13(6):1792-9. PubMed ID: 25503645
[TBL] [Abstract][Full Text] [Related]
12. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
[TBL] [Abstract][Full Text] [Related]
13. Halogenated analogs of 1'-acetoxychavicol acetate, Rev-export inhibitor from Alpinia galanga, designed from mechanism of action.
Tamura S; Shiomi A; Kimura T; Murakami N
Bioorg Med Chem Lett; 2010 Apr; 20(7):2082-5. PubMed ID: 20219373
[TBL] [Abstract][Full Text] [Related]
14. PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA.
Invernizzi CF; Xie B; Richard S; Wainberg MA
Retrovirology; 2006 Dec; 3():93. PubMed ID: 17176473
[TBL] [Abstract][Full Text] [Related]
15. Potent inhibition of HIV-1 replication by backbone cyclic peptides bearing the Rev arginine rich motif.
Chaloin L; Smagulova F; Hariton-Gazal E; Briant L; Loyter A; Devaux C
J Biomed Sci; 2007 Sep; 14(5):565-84. PubMed ID: 17520355
[TBL] [Abstract][Full Text] [Related]
16. Chimeras containing influenza NS1 and HIV-1 Rev protein sequences: mechanism of their inhibition of nuclear export of Rev protein-RNA complexes.
Chen Z; Li Y; Krug RM
Virology; 1998 Feb; 241(2):234-50. PubMed ID: 9499798
[TBL] [Abstract][Full Text] [Related]
17. RNA helicase MOV10 functions as a co-factor of HIV-1 Rev to facilitate Rev/RRE-dependent nuclear export of viral mRNAs.
Huang F; Zhang J; Zhang Y; Geng G; Liang J; Li Y; Chen J; Liu C; Zhang H
Virology; 2015 Dec; 486():15-26. PubMed ID: 26379090
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the CRM1-mediated nucleocytoplasmic transport by N-azolylacrylates: structure-activity relationship and mechanism of action.
Van Neck T; Pannecouque C; Vanstreels E; Stevens M; Dehaen W; Daelemans D
Bioorg Med Chem; 2008 Nov; 16(21):9487-97. PubMed ID: 18835718
[TBL] [Abstract][Full Text] [Related]
19. Alterations in HIV-1 Rev transport in response to cell stress.
Soros V; Cochrane A
Virology; 2001 Feb; 280(2):199-210. PubMed ID: 11162834
[TBL] [Abstract][Full Text] [Related]
20. Rev-derived peptides inhibit HIV-1 replication by antagonism of Rev and a co-receptor, CXCR4.
Shimane K; Kodama EN; Nakase I; Futaki S; Sakurai Y; Sakagami Y; Li X; Hattori T; Sarafianos SG; Matsuoka M
Int J Biochem Cell Biol; 2010 Sep; 42(9):1482-8. PubMed ID: 20580677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
